miR-195-5p also inhibits the proliferation of CRC cell lines through targeting fibroblast growth factor 2 (FGF2) and subsequent decreases in CCNB1, cyclin D2 (CCND2) and cyclin-dependent kinase 2 (CDK2) levels [176], as well as reduced cell viability by targeting BCL2 [177]. Here, CDK2 is linked to colorectal carcinoma.